PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.5971
+0.0061 (1.03%)
At close: Jul 3, 2025, 1:00 PM
0.5973
+0.0002 (0.03%)
After-hours: Jul 3, 2025, 4:13 PM EDT
PAVmed Employees
PAVmed had 39 employees as of December 31, 2024. The number of employees decreased by 68 or -63.55% compared to the previous year.
Employees
39
Change (1Y)
-68
Growth (1Y)
-63.55%
Revenue / Employee
$51,103
Profits / Employee
$1,857,667
Market Cap
10.52M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PAVM News
- 10 days ago - PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing - PRNewsWire
- 16 days ago - Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test - PRNewsWire
- 4 weeks ago - PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute - PRNewsWire
- 5 weeks ago - Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes - PRNewsWire
- 7 weeks ago - PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results - PRNewsWire
- 7 weeks ago - Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025 - PRNewsWire